Viewing Study NCT01895361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2026-01-01 @ 5:10 PM
Study NCT ID: NCT01895361
Status: COMPLETED
Last Update Posted: 2020-01-31
First Post: 2013-07-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
Sponsor: Reprixys Pharmaceutical Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SelG1 View
None P-selectin View
None monoclonal antibody View
None sickle cell disease View
None sickle cell anemia View
None sickle cell View
None pain crisis View
None pain crises View
None vasoocclusion View
None vaso-occlusion View
None priapism View
None hepatic sequestration View
None splenic sequestration View
None chest syndrome View
None SCD View